Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds NSTG.
No tracked institution reports a position in NSTG as of their last filing.
No one on the platform has traded NSTG yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $273M | +15.4% | $-0.64 | $-0.64–$-0.64 | — | 1 |
| 2027 | $348M | +27.4% | $-0.61 | $-0.61–$-0.61 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 0 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2024-02-27 | $-0.76 | $-0.95 | -25.0% |
| 2023-11-06 | $-0.53 | $-0.78 | -47.2% |
| 2023-08-03 | $-0.70 | $-0.92 | -31.4% |
| 2023-05-03 | $-0.72 | $-0.88 | -22.2% |
| 2023-02-28 | $-0.61 | $-0.95 | -55.7% |
| 2022-11-07 | $-0.51 | $-0.79 | -54.9% |
| 2022-08-04 | $-0.62 | $-0.85 | -37.1% |
| 2022-05-10 | $-0.54 | $-0.86 | -59.3% |
| $5M |
| — |
| NEUPNeuphoria Therapeutics Inc. | $3.85 | +0.65% | $21M | — |
| NVTAInvitae Corporation | $0.02 | -35.59% | $5M | — |
Source: Financial Modeling Prep · peers by sector/industry